BioSpace News Archive

Business

CNSI Names Carl Rosenblatt Executive Vice President, Chief Business Development Officer

National Health IT Firm Gears Up for Growth

April 24, 2019
·
2 min read
FDA

Belite Bio Announces FDA Approval of Investigational New Drug (IND) for Phase 1 Clinical Trial of LBS-008 to Treat Macular Degeneration and Stargardt Disease

Initiation of the Phase 1 trial is an important milestone for LBS-008, which was funded by the NIH Blueprint Program starting from lead optimization to a preclinical proof of concept

April 24, 2019
·
2 min read
Pharm Country

Feel Fresh. Period!

Feminine Care Leader Summer’s Eve® Taps Into Consumer Insights to Create Period-Focused Line

April 24, 2019
·
3 min read
Oncopeptides Provides New Guidance on the Patient Recruitment in the OCEAN Study and a Clinical Program Update in a Webcast at 10:00 (CET)

Oncopeptides AB announces that the company will provide an update on patient recruitment in the ongoing phase 3 study OCEAN, as well as a general update from all the company’s clinical studies in a webcast at 10.00am.

April 24, 2019
·
5 min read
Deals

Ipsen Reports Strong Double-Digit Sales Growth in First Quarter 2019 and Confirms Full Year 2019 Financial Targets

Ipsen, a global specialty-driven biopharmaceutical group, announced its sales for the first quarter of 2019.

April 24, 2019
·
14 min read
Business

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases

Aptorum Group Limited announced the establishment of a new subsidiary group, Smart Pharma, which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the “Smart-ACTTM” platform.

April 24, 2019
·
5 min read
Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

Topline data from ORCA-1 trial expected in the Second Quarter of 2019

April 24, 2019
·
4 min read
Deals

BerGenBio ASA: Invitation to First Quarter Presentation and Webcast

BerGenBio ASA, will announce its results for the first quarter on Wednesday, 8 May 2019.

April 24, 2019
·
2 min read
Deals

Thermo Fisher Scientific Reports First Quarter 2019 Results

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the first quarter ended March 30, 2019.

April 24, 2019
·
11 min read
Genetown

Ra Pharmaceuticals Presents Pre-Clinical Data for Zilucoplan XR at the 6th Annual Peptides Congress

Zilucoplan XR achieved rapid and sustained pharmacodynamic inhibition of complement C5 in non-human primates, supporting once weekly or less frequent dosing

April 24, 2019
·
4 min read